Live Chat Software
05 - 07 November, 2019 | London, United Kingdom
Richard Klein, Fellow,GE2P2 Global Foundation: Government, Ethics, Evidence, Policy and Practice at Formerly Director, Patient Liaison Programme, FDA
Formerly Director, Patient Liaison Programme, FDA Logo

Richard Klein


Fellow,GE2P2 Global Foundation: Government, Ethics, Evidence, Policy and Practice
Formerly Director, Patient Liaison Programme, FDA

Conference Day Two

Wednesday, November 6th, 0019


11:20 AM Understanding the FDA Approach to Expanded Access and Project Facilitate

  • Deep-dive into the new FDA pilot project ‘Facilitate’, analysing how the project will influence your Early Access Programme and relationship with the regulator
  • Help push the Industry Forward: Understand responsibilities under U.S. expanded access rules, transparency, and how to communicate with patients about access programmes 
  • Explore the social and political influences that are currently directing US legislation, spotlighting the ‘Right-to-Try’ Movement and what we might expect of future policy and regulations

Check out the incredible speaker line-up to see who will be joining Richard.

Download The Latest Agenda